TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,223,804 | +34.3% | 143,732 | +36.4% | 0.00% | 0.0% |
| Q2 2023 | $1,655,682 | -1.1% | 105,401 | +3.8% | 0.00% | 0.0% |
| Q1 2023 | $1,674,228 | +9.8% | 101,559 | +4.0% | 0.00% | 0.0% |
| Q4 2022 | $1,524,178 | +24.5% | 97,608 | +3.5% | 0.00% | 0.0% |
| Q3 2022 | $1,224,000 | -16.3% | 94,352 | -9.5% | 0.00% | 0.0% |
| Q2 2022 | $1,463,000 | -24.3% | 104,274 | +5.7% | 0.00% | -25.0% |
| Q1 2022 | $1,933,000 | +38.7% | 98,617 | -3.5% | 0.00% | +33.3% |
| Q4 2021 | $1,394,000 | -28.7% | 102,170 | -14.2% | 0.00% | -25.0% |
| Q3 2021 | $1,956,000 | -7.9% | 119,102 | -5.6% | 0.00% | -20.0% |
| Q2 2021 | $2,123,000 | +9.0% | 126,112 | +18.3% | 0.01% | 0.0% |
| Q1 2021 | $1,948,000 | +14.5% | 106,594 | +13.8% | 0.01% | 0.0% |
| Q4 2020 | $1,702,000 | +18.9% | 93,688 | +16.6% | 0.01% | +25.0% |
| Q3 2020 | $1,432,000 | +16.2% | 80,374 | +16.9% | 0.00% | 0.0% |
| Q2 2020 | $1,232,000 | +20.5% | 68,740 | +2.9% | 0.00% | 0.0% |
| Q1 2020 | $1,022,000 | – | 66,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |